A study on the immunogenicity and safety of 3 different dose concentrations of a respiratory syncytial virus vaccine in infants and toddlers

Trial Identifier: VAD00015
Sponsor: Sanofi Pasteur, a Sanofi Company
Start Date: November 2024
Primary Completion Date: June 2025
Study Completion Date: June 2025
Condition: Respiratory Syncytial Virus Immunisation; Healthy Volunteers

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description

Trial Locations

Country Location
HONDURAS SAN PEDRO SULA, HONDURAS, NULL
HONDURAS TEGUCIGALPA, HONDURAS, 11101